Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Booster Study
NCT00570193Phase 2Completed
- Start
- Dec 2006
- Primary completion
- Jun 2011
- Modality
- Light/Condition-Responsive Prodrugs
01
Overview
A Phase 2 trial of verteporfin in choroidal neovascularization (CNV). Started Dec 2006; status: completed.
02
Drugs
verteporfin
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00570193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570193.